Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05904028
What this trial is testing

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Jaeb Center for Health Research 603
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Large-scale testing (Phase 3)UnknownNCT00710229
What this trial is testing

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableWithdrawnNCT00447031
What this trial is testing

Combination Therapy for Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Yonsei University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816315
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)

Who this might be right for
Wet Age Related Macular Degeneration
Ollin Biosciences, Inc. 500
Post-approval studies (Phase 4)UnknownNCT01918878
What this trial is testing

Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.

Who this might be right for
Neovascular Age-related Macular Degeneration
Hadassah Medical Organization 48
Not applicableEnded earlyNCT01337414
What this trial is testing

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Johns Hopkins University 324
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Large-scale testing (Phase 3)Looking for participantsNCT07516132
What this trial is testing

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Ocular Therapeutix, Inc. 850
Not applicableLooking for participantsNCT07427160
What this trial is testing

Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages

Who this might be right for
AMD - Age-Related Macular Degeneration
Marco Mazzola 60
Large-scale testing (Phase 3)Study completedNCT00599222
What this trial is testing

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Anders Kvanta 100
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Large-scale testing (Phase 3)Study completedNCT05282004
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 36
Large-scale testing (Phase 3)Study completedNCT00685100
What this trial is testing

Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone

Who this might be right for
Neovascular Age Related Macular Degeneration
Medical University of Vienna 40
Early research (Phase 1)Study completedNCT01186432
What this trial is testing

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Forsight Vision4 20
Testing effectiveness (Phase 2)Ended earlyNCT03465709
What this trial is testing

Pegcetacoplan (APL-2) in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01157715
What this trial is testing

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 122
Early research (Phase 1)Study completedNCT04058535
What this trial is testing

Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alteogen, Inc. 28
Early research (Phase 1)UnknownNCT03021785
What this trial is testing

Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Jiangsu T-Mab Biopharma Co.,Ltd 36
Post-approval studies (Phase 4)Ended earlyNCT04287348
What this trial is testing

Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 16
Next Page